A Bayesian Stopping Rule for Sequential Monitoring of Serious Adverse Events

Therapeutic Innovation & Regulatory Science
Kosuke KashiwabaraYasuo Ohashi

Abstract

In an ongoing clinical trial, there will always be a risk for unanticipated critical safety problems, such as excessive occurrence of serious adverse events. When such a problem arises, the trial administrators must conduct an immediate evaluation to determine whether the trial should be terminated to protect patients. This decision is complicated but may be aided by statistical stopping rules. Sequential stopping rules are appropriate for immediate decisions, but frequentist approaches may not be useful because the unknown truncated end of the trial makes it impossible to define type I errors. Thus, a Bayesian stopping rule is proposed that is based on the posterior distribution with an informative prior distribution, and a guideline to construct this stopping rule is presented. Some operating characteristics are evaluated and compared with those of the modified sequential probability ratio test (SPRT), the maximized SPRT, and Pocock's test. The proposed method has flexibility for construction and could provide a more desirable performance than the other compared methods.

References

Jun 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R Mehta, K C Cain
Sep 30, 1994·Statistics in Medicine·J GrossmanL S Freedman
Aug 1, 1993·Statistics in Medicine·D A Berry
Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P F ThallE H Estey
Oct 21, 2003·Statistics in Medicine·K K Gordon LanOliver Bautista
Nov 12, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Donald A Berry
Aug 28, 2010·Statistics in Medicine·Mei-Chiung ShihJie Chen

❮ Previous
Next ❯

Citations

Aug 18, 2016·CPT: Pharmacometrics & Systems Pharmacology·G SmaniaP Magni

❮ Previous
Next ❯

Software Mentioned

BAYES
MaxSPRT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.